Prognostic significance of insulin-like growth factor 1 receptors in human breast cancer.
暂无分享,去创建一个
R Beuscart | J. Bonneterre | J. Peyrat | R. Beuscart | J. Peyrat | J Bonneterre | J P Peyrat | A Demaille | J. Bonneterre | A. Demaille
[1] R. Furlanetto,et al. Somatomedin-C receptors and growth effects in human breast cells maintained in long-term tissue culture. , 1984, Cancer research.
[2] R. Margolese,et al. Presence of somatomedin receptors on primary human breast and colon carcinomas. , 1987, Cancer letters.
[3] J. Bonneterre,et al. Insulin-like growth factor 1 receptors in human breast cancer and their relation to estradiol and progesterone receptors. , 1988, Cancer Research.
[4] A. Stiles,et al. Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[5] D. Wilson,et al. Demonstration of insulin-like growth factor (IGF-I and -II) receptors and binding protein in human breast cancer cell lines. , 1988, Biochemical and biophysical research communications.
[6] J. Bonneterre,et al. Characterization of insulin-like growth factor 1 receptors (IGF1-R) in human breast cancer cell lines. , 1989, Bulletin du cancer.
[7] B. Moats-Staats,et al. Somatomedin-C/insulin-like growth factor-I and insulin-like growth factor-II mRNAs in rat fetal and adult tissues. , 1986, The Journal of biological chemistry.
[8] J. Bonneterre,et al. Presence and characterization of insulin-like growth factor 1 receptors in human benign breast disease. , 1988, European journal of cancer & clinical oncology.
[9] J. Bonneterre,et al. Prognostic significance of prolactin receptors in human breast cancer. , 1987, Cancer research.
[10] Kenneth P. Karey,et al. Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17 beta-estradiol. , 1988, Cancer research.
[11] W. Daughaday,et al. Serum somatomedin binding proteins: physiologic significance and interference in radioligand assay. , 1987, The Journal of laboratory and clinical medicine.
[12] J. Perdue. Chemistry, structure, and function of insulin-like growth factors and their receptors: a review. , 1984, Canadian journal of biochemistry and cell biology = Revue canadienne de biochimie et biologie cellulaire.
[13] J. Bonneterre,et al. Correlation between prolactin receptors (PRL R), estradiol (ER) and progesterone receptors (PgR) in human breast cancer. , 1986, European journal of cancer & clinical oncology.
[14] R. Furlanetto,et al. Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay. , 1977, The Journal of clinical investigation.
[15] D. Yee,et al. The insulin-like growth factor binding protein BP-25 is expressed by human breast cancer cells. , 1989, Biochemical and biophysical research communications.
[16] R. Dickson,et al. Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. , 1987, Endocrine reviews.
[17] D.,et al. Regression Models and Life-Tables , 2022 .
[18] A. N. Corps,et al. The insulin-like growth factor I content in human milk increases between early and full lactation. , 1988, The Journal of clinical endocrinology and metabolism.
[19] R. Shiu,et al. Receptor binding and growth-promoting activity of insulin-like growth factors in human breast cancer cells (T-47D) in culture. , 1984, Cancer research.
[20] W. McGuire,et al. Specific progesterone receptors in human breast cancer , 1975, Steroids.
[21] J. Foekens,et al. Prognostic value of receptors for insulin-like growth factor 1, somatostatin, and epidermal growth factor in human breast cancer. , 1989, Cancer research.
[22] R. Sutherland,et al. HIGH MOLECULAR WEIGHT SOMATOMEDIN-C/IGF-I FROM T47D HUMAN MAMMARY CARCINOMA CELLS: IMMUNOREACTIVITY AND BIOACTIVITY , 1983 .
[23] O. H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[24] S Friedman,et al. The importance of histologic grade in long-term prognosis of breast cancer: a study of 1,010 patients, uniformly treated at the Institut Gustave-Roussy. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] D. Kaufman,et al. Secretion of an insulin-like growth factor-I-related protein by human breast cancer cells. , 1986, Cancer research.
[26] E. Froesch,et al. Pathophysiological and clinical aspects of the insulin-like growth factors. , 1986, Hormone research.
[27] G. Bell,et al. Tissue distribution of insulin-like growth factor I and II messenger ribonucleic acid in the adult rat. , 1987, Endocrinology.
[28] C. Polychronakos,et al. Characterization of insulin-like growth factor I (IGF-I) receptors of human breast cancer cells. , 1988, Biochemical and biophysical research communications.
[29] D. Wilson,et al. Characterization of insulin-like growth factor binding proteins from human breast cancer cells. , 1989, Molecular endocrinology.
[30] A. Nicolin,et al. Partial characterization of somatomedin C-like immunoreactivity secreted by breast cancer cells in vitro , 1987, Molecular and Cellular Endocrinology.
[31] A. Koenders,et al. Standardization of steroid receptor assays in human breast cancer--IV. Long-term within- and between-laboratory variation of estrogen and progesterone receptor assays. , 1986, European journal of cancer & clinical oncology.
[32] D. Yee,et al. Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer. , 1989, Molecular endocrinology.